Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
Annals of Hematology
|
April 24, 2022
Concomitant multiple sclerosis and polycythemia vera successfully treated with glatiramer acetate
Ivan Krečak, Sandra Celić-Bunikić, Marko Skelin, et al.
Journal of Chemotherapy (Florence, Italy)
|
May 13, 2022
The effect of PARP inhibitors in homologous recombination proficient ovarian cancer: meta-analysis
Marko Skelin, David Šarčević, Dina Lešin Gaćina, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
March 30, 2023
Hematocrit to hemoglobin ratio (HHR) may improve prognostication in patients with pulmonary embolism
Ivan Krečak, Monika Čeko, Karla Nižetić, et al.
Journal of Chemotherapy (Florence, Italy)
|
April 23, 2025
Immunotherapy in mesothelioma - systematic review and meta-analysis of immunotherapy impact on OS and its correlation with PFS and ORR
Marko Skelin, Kaja Matić, Andrea Anić-Matić, et al.
Reviews in Cardiovascular Medicine
|
January 29, 2022
Comparison of media and academic attention of recently published positive and neutral or negative randomized cardiovascular clinical trials
Marko Skelin, Josip Katić, David Šarčević, et al.
Pharmacology Research & Perspectives
|
July 7, 2025
Aspirin Versus LMWH for Thromboprophylaxis Following Hip or Knee Arthroplasty-Clinical Implications and Budget Impact
Eugen Javor, Andrej Belančić, Patrik Javor, et al.
Heliyon
|
August 26, 2024
No impact of steatotic liver disease on clinical outcomes in patients with essential thrombocythemia and polycythemia vera: A pilot study
Ivan Krečak, Josipa Antonija Bačić, Nevena Šimunić, et al.
Pharmacology
|
January 3, 2024
Prolonged Proton Pump Inhibitor Use and Thrombohemorrhagic Risk in Essential Thrombocythemia and Polycythemia Vera Patients Treated with Long-Term Aspirin: A Pilot Study
Ivan Krečak, Ljerka Pivac, Hrvoje Holik, et al.
Oncology Research
|
April 30, 2024
Levels of evidence and grades of recommendation supporting European society for medical oncology clinical practice guidelines
Marko Skelin, Bruna Perkov-Stipičin, Sanja Vušković, et al.
Acta Diabetologica
|
April 6, 2026
Differentiating polycythemia vera from sodium-glucose cotransporter 2 inhibitor-associated polycythemia
Ivan Krecak, Marija Valovicic Krecak, Tina Marketin, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
Annals of Hematology
|
April 24, 2022
Concomitant multiple sclerosis and polycythemia vera successfully treated with glatiramer acetate
Ivan Krečak, Sandra Celić-Bunikić, Marko Skelin, et al.
Journal of Chemotherapy (Florence, Italy)
|
May 13, 2022
The effect of PARP inhibitors in homologous recombination proficient ovarian cancer: meta-analysis
Marko Skelin, David Šarčević, Dina Lešin Gaćina, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
March 30, 2023
Hematocrit to hemoglobin ratio (HHR) may improve prognostication in patients with pulmonary embolism
Ivan Krečak, Monika Čeko, Karla Nižetić, et al.
Journal of Chemotherapy (Florence, Italy)
|
April 23, 2025
Immunotherapy in mesothelioma - systematic review and meta-analysis of immunotherapy impact on OS and its correlation with PFS and ORR
Marko Skelin, Kaja Matić, Andrea Anić-Matić, et al.
Reviews in Cardiovascular Medicine
|
January 29, 2022
Comparison of media and academic attention of recently published positive and neutral or negative randomized cardiovascular clinical trials
Marko Skelin, Josip Katić, David Šarčević, et al.
Pharmacology Research & Perspectives
|
July 7, 2025
Aspirin Versus LMWH for Thromboprophylaxis Following Hip or Knee Arthroplasty-Clinical Implications and Budget Impact
Eugen Javor, Andrej Belančić, Patrik Javor, et al.
Heliyon
|
August 26, 2024
No impact of steatotic liver disease on clinical outcomes in patients with essential thrombocythemia and polycythemia vera: A pilot study
Ivan Krečak, Josipa Antonija Bačić, Nevena Šimunić, et al.
Pharmacology
|
January 3, 2024
Prolonged Proton Pump Inhibitor Use and Thrombohemorrhagic Risk in Essential Thrombocythemia and Polycythemia Vera Patients Treated with Long-Term Aspirin: A Pilot Study
Ivan Krečak, Ljerka Pivac, Hrvoje Holik, et al.
Oncology Research
|
April 30, 2024
Levels of evidence and grades of recommendation supporting European society for medical oncology clinical practice guidelines
Marko Skelin, Bruna Perkov-Stipičin, Sanja Vušković, et al.
Acta Diabetologica
|
April 6, 2026
Differentiating polycythemia vera from sodium-glucose cotransporter 2 inhibitor-associated polycythemia
Ivan Krecak, Marija Valovicic Krecak, Tina Marketin, et al.
Page
of 7